CS logo
small CS logo
MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak

Wroclaw, Poland
Pain control clinic in Wrocław
Łubinowa 12/7, 52-210 Wrocław

About MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


"Specjalizujemy się w diagnozowaniu i leczeniu bólów głowy. Stosujemy nowoczesne, zgodne ze światowymi standardami leczenia bólów głowy na świecie metody, takie jak: leczenie toksyną botulinową (botox), blokady nerwowe, zoptymalizowana farmakoterapia i wiele innych. Wzorując się na metodach stosowanych w najsłynniejszej Klinice Mayo w USA poprawiamy jakość życia pacjentów z bólami głowy. Nie jest prawdą funkcjonujący w Polsce mit, że z bólem głowy trzeba nauczyć się żyć. Korzystając ze zdobyczy światowej medycyny, jesteśmy w stanie zaoferować Państwu realną pomoc. dr. n med. Anna Gryglas-Dworak specjalista neurolog"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
3
Pfizer
2
Total Rows: 2

Clinical Trials at MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


During the past decade, MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221122000000Started TrialsCompleted Trails2019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
2019-09-05
2027-06-28
Recruiting
286
Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine
2019-07-19
2027-05-05
Recruiting
456
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
2020-09-15
2024-07-21
Recruiting
576
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
2021-01-15
2031-07-15
Recruiting
2,100
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
2021-04-28
2024-12-31
Recruiting
600

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak" #1 collaborator was "Novartis" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 3Amgen: 3Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top CollaboratorsNovartis: 2Novartis: 2

Clinical Trials Conditions at MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


According to Clinical.Site data, the most researched conditions in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak" are "Migraine" (3 trials), "Acute Treatment of Migraine" (1 trials) and "Pediatric Migraine" (1 trials). Many other conditions were trialed in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak" in a lesser frequency.

Clinical Trials Intervention Types at MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


Most popular intervention types in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "Erenumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


The vast majority of trials in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak" are 5 trials for "All" genders.

Clinical Trials Status at MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak


Currently, there are NaN active trials in "MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 5Recruiting: 5